Land: Irland
Språk: engelska
Källa: HPRA (Health Products Regulatory Authority)
CICLOSPORIN
Novartis Animal Health UK Ltd
QL04AA01
100 Milligram
Capsules, Soft
Miscellaneous
Canine
2009-06-01
IRISH MEDICINES BOARD ACT 1995 EUROPEAN COMMUNITIES (ANIMAL REMEDIES) (NO. 2) REGULATIONS 2007 (S.I. NO. 786 OF 2007) 10825/005/004 Case No: 7005491 Transferred from 10835/049/004. The Irish Medicines Board in exercise of the powers conferred on it by the Animal Remedies (No. 2) Regulations (S.I. No. 786 of 2007) hereby grants to: NOVARTIS ANIMAL HEALTH UK LTD FRIMLEY BUSINESS PARK, FRIMLEY, SURREY GU16 7SR, ENGLAND an authorisation, subject to the provisions of the said Regulations and the general conditions of the attached authorisation, in respect of the Veterinary Medicinal Product: ATOPICA 100 MG SOFT CAPSULES FOR DOGS The particulars of which are set out in Part 1 and Part 2 of the said Schedule. The authorisation is also subject to any special conditions as may be specified in the said schedule. The authorisation,unless revoked, shall continue in force from 01/06/2009. Signed on behalf of the Irish Medicines Board ________________ A person authorised in that behalf by the said Board. (NOTE: This authorisation replaces any previous authorisation in respect of this product which is now null and void.) IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 06/06/2009_ _CRN 7005491_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT ATOPICA 100 mg soft capsules for dogs 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE: Ciclosporin 100.00 mg EXCIPIENT(S): -tocopherol (E-307) 1.00 mg Iron oxide black (E-172) 0.285 mg Titanium dioxide (E-171) 5.73 mg Carminic acid (E-120) < 1.00 ug For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Soft capsule Blue-grey oblong capsules bearing the following imprint: NVR and 100 mg. 4 CLI Läs hela dokumentet